APPLICATION
ANDA214022
TYPE
ANDA
ORIGINAL APPROVAL
2026-02-11
LATEST ACTION
2026-02-11
ROUTE
SUBCUTANEOUS
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
GLATIRAMER ACETATEPrescription
GLATIRAMER ACETATE 40MG/ML · INJECTABLE · SUBCUTANEOUS
Approval history
2026-02-11UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.